ReviewBreast cancer (Dove Medical Press)2024

Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer.

Kaitlyn O'Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.